Compare AAON & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAON | KYMR |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.8B |
| IPO Year | 1995 | 2020 |
| Metric | AAON | KYMR |
|---|---|---|
| Price | $90.54 | $84.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 26 |
| Target Price | $107.75 | ★ $108.04 |
| AVG Volume (30 Days) | ★ 882.2K | 747.1K |
| Earning Date | 06-02-2026 | 05-18-2026 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $1,442,076,000.00 | $39,211,000.00 |
| Revenue This Year | $10.47 | $16.05 |
| Revenue Next Year | $15.07 | $4.79 |
| P/E Ratio | $68.64 | ★ N/A |
| Revenue Growth | ★ 20.11 | N/A |
| 52 Week Low | $62.00 | $19.45 |
| 52 Week High | $116.04 | $103.00 |
| Indicator | AAON | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 50.87 |
| Support Level | $88.95 | $66.33 |
| Resistance Level | $96.96 | $95.90 |
| Average True Range (ATR) | 4.93 | 4.53 |
| MACD | -1.76 | -0.97 |
| Stochastic Oscillator | 18.01 | 26.08 |
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.